[HTML][HTML] Towards a treatment for neuroinflammation in epilepsy: interleukin-1 receptor antagonist, anakinra, as a potential treatment in intractable epilepsy
G Yamanaka, Y Ishida, K Kanou, S Suzuki… - International Journal of …, 2021 - mdpi.com
Febrile Infection-Related Epilepsy Syndrome (FIRES) is a unique catastrophic epilepsy
syndrome, and the development of drug-resistant epilepsy (DRE) is inevitable. Recently …
syndrome, and the development of drug-resistant epilepsy (DRE) is inevitable. Recently …
Towards a Treatment for Neuroinflammation in Epilepsy: Interleukin-1 Receptor Antagonist, Anakinra, as a Potential Treatment in Intractable Epilepsy
G Yamanaka, Y Ishida, K Kanou, S Suzuki… - 2021 - agris.fao.org
Febrile Infection-Related Epilepsy Syndrome (FIRES) is a unique catastrophic epilepsy
syndrome, and the development of drug-resistant epilepsy (DRE) is inevitable. Recently …
syndrome, and the development of drug-resistant epilepsy (DRE) is inevitable. Recently …
Towards a Treatment for Neuroinflammation in Epilepsy: Interleukin-1 Receptor Antagonist, Anakinra, as a Potential Treatment in Intractable Epilepsy.
G Yamanaka, Y Ishida, K Kanou, S Suzuki… - … Journal of Molecular …, 2021 - europepmc.org
Abstract Febrile Infection-Related Epilepsy Syndrome (FIRES) is a unique catastrophic
epilepsy syndrome, and the development of drug-resistant epilepsy (DRE) is inevitable …
epilepsy syndrome, and the development of drug-resistant epilepsy (DRE) is inevitable …
[HTML][HTML] Towards a Treatment for Neuroinflammation in Epilepsy: Interleukin-1 Receptor Antagonist, Anakinra, as a Potential Treatment in Intractable Epilepsy
G Yamanaka, Y Ishida, K Kanou, S Suzuki… - … Journal of Molecular …, 2021 - ncbi.nlm.nih.gov
Abstract Febrile Infection-Related Epilepsy Syndrome (FIRES) is a unique catastrophic
epilepsy syndrome, and the development of drug-resistant epilepsy (DRE) is inevitable …
epilepsy syndrome, and the development of drug-resistant epilepsy (DRE) is inevitable …
Towards a Treatment for Neuroinflammation in Epilepsy: Interleukin-1 Receptor Antagonist, Anakinra, as a Potential Treatment in Intractable Epilepsy
G Yamanaka, Y Ishida, K Kanou… - International …, 2021 - pubmed.ncbi.nlm.nih.gov
Febrile Infection-Related Epilepsy Syndrome (FIRES) is a unique catastrophic epilepsy
syndrome, and the development of drug-resistant epilepsy (DRE) is inevitable. Recently …
syndrome, and the development of drug-resistant epilepsy (DRE) is inevitable. Recently …
[PDF][PDF] Towards a Treatment for Neuroinflammation in Epilepsy: Interleukin-1 Receptor Antagonist, Anakinra, as a Potential Treatment in Intractable Epilepsy
G Yamanaka, Y Ishida, K Kanou, S Suzuki… - Int. J. Mol …, 2021 - pdfs.semanticscholar.org
Febrile Infection-Related Epilepsy Syndrome (FIRES) is a unique catastrophic epilepsy
syndrome, and the development of drug-resistant epilepsy (DRE) is inevitable. Recently …
syndrome, and the development of drug-resistant epilepsy (DRE) is inevitable. Recently …
Towards a Treatment for Neuroinflammation in Epilepsy: Interleukin-1 Receptor Antagonist, Anakinra, as a Potential Treatment in Intractable Epilepsy
G Yamanaka, Y Ishida, K Kanou, S Suzuki… - International Journal of …, 2021 - cir.nii.ac.jp
抄録< jats: p> Febrile Infection-Related Epilepsy Syndrome (FIRES) is a unique catastrophic
epilepsy syndrome, and the development of drug-resistant epilepsy (DRE) is inevitable …
epilepsy syndrome, and the development of drug-resistant epilepsy (DRE) is inevitable …
Towards a Treatment for Neuroinflammation in Epilepsy: Interleukin-1 Receptor Antagonist, Anakinra, as a Potential Treatment in Intractable Epilepsy.
G Yamanaka, Y Ishida, K Kanou… - International …, 2021 - search.ebscohost.com
Abstract Febrile Infection-Related Epilepsy Syndrome (FIRES) is a unique catastrophic
epilepsy syndrome, and the development of drug-resistant epilepsy (DRE) is inevitable …
epilepsy syndrome, and the development of drug-resistant epilepsy (DRE) is inevitable …